Phase 2 Postmenopausal Women Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women
Postmenopausal Women
Odense University Hospital136 enrolled2 locationsNCT06789900
Completed
Phase 2
An open-label, phase 2, single centre, randomised, crossover pharmacokinetic study assessing two application areas of 0.5ml (5mg) of a testosterone 1% cream, ANDROFEME(Registered trademark) in healthy postmenopausal women
Androgen deficiency in postmenopausal women
Lawley Pharmaceuticals20 enrolled1 locationACTRN12614000962639
Completed
Phase 2
An open-label, phase 2, single centre, randomised, crossover study of two doses of Androfeme in healthy postmenopausal women
determination of blood testosterone levels using two doses of Androfem cream in postmenopausal women
Monash University8 enrolled1 locationACTRN12612001250820
Completed
Phase 2
The effect of transdermal testosterone gel300mcg daily on cognitive performance in older postmenopausal women: a placebo controlled trial over 26 weeks
cognition in older postmenopausal women
Monash University120 enrolled1 locationACTRN12609000981224